Close Menu

NEW YORK (GenomeWeb) – Qiagen said today that it has acquired molecular oncology decision company N-of-One. Terms were not disclosed, but Qiagen said it made the purchase with cash reserves.

In purchasing Concord, Massachusetts-based N-of-One, Qiagen expects to beef up its offerings in decision support and offer its customers better clinical interpretation technologies for genomic data in pursuit of new, targeted therapies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.